Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer

Serum testosterone is a potential marker to distinguish between indolent and aggressive prostate cancer (PCa). The present study aimed to investigate whether low levels of total serum testosterone at diagnosis were associated with aggressive PCa and poor clinical outcomes. In total, 762 non-Hispanic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Tu, Huakang, Gu, Jian, Meng, Qing H., Kim, Jeri, Strom, Sara, Davis, John W., He, Yonggang, Wagar, Elizabeth A., Thompson, Timothy C., Logothetis, Christopher J., Wu, Xifeng
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2017
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403694/
https://ncbi.nlm.nih.gov/pubmed/28454349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5616
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky